PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.58%
Negative revenue growth while FSLR stands at 91.01%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-21.95%
Negative gross profit growth while FSLR is at 321.96%. Joel Greenblatt would examine cost competitiveness or demand decline.
-32.27%
Negative EBIT growth while FSLR is at 181.49%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-195.63%
Negative operating income growth while FSLR is at 181.49%. Joel Greenblatt would press for urgent turnaround measures.
167.94%
Net income growth at 50-75% of FSLR's 251.69%. Martin Whitman would question fundamental disadvantages in expenses or demand.
168.87%
EPS growth at 50-75% of FSLR's 251.61%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
155.10%
Diluted EPS growth at 50-75% of FSLR's 250.00%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
1.77%
Share count expansion well above FSLR's 0.99%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
18.91%
Diluted share count expanding well above FSLR's 1.23%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-86.96%
Negative OCF growth while FSLR is at 95.91%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-82.83%
Negative FCF growth while FSLR is at 88.19%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
204.54%
10Y revenue/share CAGR under 50% of FSLR's 3646.79%. Michael Burry would suspect a lasting competitive disadvantage.
-29.48%
Negative 5Y CAGR while FSLR stands at 28.27%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-43.62%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-246.13%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-122.15%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-319.20%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
113.47%
Below 50% of FSLR's 18208.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
174.47%
Positive 5Y CAGR while FSLR is negative. John Neff might view this as a strong mid-term relative advantage.
106.82%
Positive short-term CAGR while FSLR is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-25.53%
Negative 5Y equity/share growth while FSLR is at 40.81%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
16.39%
3Y equity/share CAGR at 50-75% of FSLR's 29.16%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.43%
Firm’s AR is declining while FSLR shows 3.39%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.59%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.98%
Asset growth above 1.5x FSLR's 1.93%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.39%
BV/share growth above 1.5x FSLR's 0.10%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.55%
We’re deleveraging while FSLR stands at 23.58%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-2.87%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
5.58%
SG&A growth well above FSLR's 4.75%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.